Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Santa Ana Bio
AddedFeb 17, 2024
UpdatedJun 18, 2026
Santa Ana Bio

Santa Ana Bio

Series A

Santa Ana Bio designs precision biologics using deep cell profiling tech, specializing in autoimmune diseases.

HQ
Alameda, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Santa Ana Bio, founded in 2021 and headquartered in Alameda, California, is a biotechnology company specializing in precision biologics for autoimmune and inflammatory diseases. The company leverages advanced multi-omics platforms and antibody engineering to design targeted therapies. Their core mission is to utilize deep cell profiling technologies to create precision medicines that address the specific needs of patients suffering from immune-mediated conditions.

Notable affiliates and investors include leading figures in biotechnology and healthcare investment sectors, although specific names are not disclosed. Santa Ana Bio has achieved significant milestones in developing precision treatments for conditions like Hidradenitis Suppurativa. Their innovative approach has the potential to revolutionize the treatment landscape for autoimmune diseases, offering more effective and personalized therapeutic options.

Santa Ana Bio - Similar Companies

HI-Bio logo

HI-Bio

hibio.com

Ancora Biotech logo

Ancora Biotech

ancorabiotech.com

Scribe Biosciences logo

Scribe Biosciences

Seranova Bio logo

Seranova Bio

seranovabio.com

Dren Bio logo

Dren Bio

drenbio.com

Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

entelexo.com

Appia Bio logo

Appia Bio

appiabio.com

Alphina Therapeutics logo

Alphina Therapeutics

EpiBiologics logo

EpiBiologics

epibiologics.com

Sonoma Biotherapeutics logo

Sonoma Biotherapeutics

Amber Bio logo

Amber Bio

amber.bio

Equillium logo

Equillium

equilliumbio.com

Califia Bio logo

Califia Bio

califiabio.com

Cadenza Bio logo

Cadenza Bio

cadenza.bio

Sujana Biotech logo

Sujana Biotech

Santa Ana Bio - Quick Facts

Who are Santa Ana Bio's competitors?

Companies similar to Santa Ana Bio include HI-Bio, Ancora Biotech, Scribe Biosciences and Seranova Bio.

When was Santa Ana Bio founded?

Santa Ana Bio was founded in 2021.

Where is Santa Ana Bio's headquarters located?

Santa Ana Bio's headquarters is located in Alameda, CA, US.

When was Santa Ana Bio's last funding round?

Santa Ana Bio's most recent funding round was for $35.3M (USD) in February 2023.

How much has Santa Ana Bio raised to-date?

As of Feb 28, 2023, Santa Ana Bio has raised a total of $35.3M (USD).

How many employees does Santa Ana Bio have?

Santa Ana Bio has 18 employees as of Feb 5, 2024.

Santa Ana Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biologics
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified